GFUZ carries only a single published analyst target, so no meaningful average or consensus exists. On November 3, 2026, Wedbush initiated coverage with a Neutral rating and $7.00 price target. Data aggregators including Yahoo Finance, MarketBeat, and TradingView reflect the same figure. Since one analyst does not form a consensus, this piece treats $7.00 as a publicly discussed objective rather than a formal consensus forecast.
The latest verified close stands at $5.16 as of November 13, 2026, within a 52-week range of $5.00 to $14.85. Achieving $7.00 would represent upside of about 36%, a substantial shift for a pre-revenue developer. Shares have declined roughly 58% from the post-listing high and now sit near the listing low around $5.14. Without revenue or positive trailing EPS, progress toward $7.00 hinges more on technical milestones, funding access, and sentiment around fusion energy than on conventional valuation measures. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
General Fusion's clearest catalyst remains technical advancement. In October 2026 the company reported a world-first 1 keV electron temperature result on LM26, developed with the United Kingdom Atomic Energy Authority and representing the first major milestone in the program. Management has outlined further steps toward 10 keV and ultimately the Lawson criterion as part of a roadmap to a commercial plant in the mid-2030s. The firm entered public markets with roughly $150 million in cash, viewed as adequate to fund LM26 into 2028, and holds a framework agreement with Renexia S.p.A. for potential deployment in Italy. Broader interest in fusion as a carbon-free baseload source adds a sentiment tailwind for an early player like GFUZ.
GFUZ reports no commercial revenue and posted a trailing net loss of roughly $144.6 million, so valuation rests entirely on future potential. The company has issued no numeric financial guidance and faces ongoing losses plus dependence on external capital. Prior financing included SAFEs that may convert into common shares and dilute existing investors. Execution risk remains central: any slippage in LM26 milestones or delays in the technical roadmap could weaken confidence and pressure the share price. The sharp post-listing drop also illustrates how sensitive the stock remains to shifts in risk appetite for speculative growth names.
GFUZ has touched a low of $5.00 and sits near its listing low around $5.14, an area that now acts as important support. Resistance appears near $8.71, while the 50-day average has hovered around $7.16. Notably, the $7.00 target lies just below that average, so the stock would need to recover through its recent moving average to approach the objective. The overall structure shows lower highs since listing, suggesting any sustained move toward $7.00 would likely require a trend shift rather than a simple bounce.
Analyst targets generally reflect a roughly 12-month horizon, and Wedbush’s $7.00 objective fits that frame, though the firm has not specified an exact timeline. Investors should monitor quarterly updates, including results expected in mid-November 2026, for cash levels, LM26 spending pace, and any new technical milestones or partnership news. Additional factors include new analyst coverage or revisions, changes in financing or dilution outlook, and overall risk appetite for pre-revenue fusion and advanced-energy names. From what I see, these updates will be key to gauging near-term direction.
Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to track thousands of stocks and ETFs in real time, producing Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI analysis. For a volatile, milestone-driven name like GFUZ, these signals can assist traders in spotting opportunities, tracking positions, and recognizing trend shifts more efficiently than manual methods alone. I find them useful as part of a broader research process when evaluating names in emerging sectors.
The $7.00 target for GFUZ remains a single, publicly discussed price objective from Wedbush’s Neutral-rated initiation rather than an analyst consensus, implying a substantial roughly 36% gain from the latest close of $5.16. The constructive case rests on verified technical progress such as the 1 keV LM26 milestone and funding visibility into 2028, while the cautious case centers on zero revenue, recurring losses, dilution risk, and the inherent uncertainty of commercializing fusion technology. With only one covering analyst and no earnings-based valuation anchor, GFUZ stays a speculative, news-driven stock where reaching $7.00 will depend heavily on execution and market sentiment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialMachinery